H Chiesi Hellas είναι από σήμερα κάτοχος αδείας κυκλοφορίας του φαρμακευτικού ιδιοσκευάσματος FLUIMUCIL

Home page > Media > Chiesi Hellas is...

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data
Date: 30/04/2013

Chiesi Hellas is currently a marketing authorization holder of the drug Fluimucil in Greece. Fluimucil is a product of the Italian company Zambon and is manufactured in Switzerland. It is an expectorant-mucolytic agent available in sachets containing granules for oral suspension. The active substance is Acetylcysteine, 600mg per sachet.